Circular RNA-Based Therapy Targeting Metabolic Vulnerability of Fatty Acid Synthesis Overcomes Castration-Resistant Prostate Cancer

Scientists identified circUTRN, an androgen receptor-inhibited circRNA that is upregulated following neoadjuvant hormonal therapy and downregulated in prostate cancer tissues.